Ars Pharmaceutica

Scope & Guideline

Pioneering research that shapes the future of pharmacy.

Introduction

Welcome to the Ars Pharmaceutica information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Ars Pharmaceutica, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN0004-2927
PublisherUNIV GRANADA, EDITORIAL
Support Open AccessNo
Country-
TypeJournal
Convergefrom 1980 to 1981, from 1983 to 1984, from 1986 to 2001, from 2003 to 2017 (coverage discontinued in Scopus)
AbbreviationARS PHARM / Ars Pharm.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressANTIGUO COLEGIO MAXIMO, CAMPUS DE CARTUJA, GRANADA 18071, SPAIN

Aims and Scopes

Ars Pharmaceutica is dedicated to advancing the field of pharmaceutical sciences through rigorous research and analysis. The journal encompasses a diverse range of topics relevant to pharmacology, drug development, clinical pharmacy, and health care practices, reflecting its commitment to improving patient care and public health.
  1. Pharmacological Research and Drug Development:
    The journal prioritizes studies related to the discovery, development, and optimization of pharmaceutical compounds, including bioavailability, pharmacokinetics, and therapeutic efficacy.
  2. Clinical Pharmacy and Therapeutics:
    A significant focus on clinical applications of pharmacy, including medication management, adherence, and the role of pharmacists in patient care.
  3. Public Health and Drug Safety:
    Research addressing drug-related problems, medication safety, and public health implications, including the evaluation of drug use patterns and adverse effects.
  4. Analytical and Methodological Advances:
    Innovations in analytical techniques for drug quantification and characterization, alongside the development of new methodologies for pharmaceutical research.
  5. Ethnopharmacology and Natural Products:
    Investigation of traditional medicine and natural compounds, assessing their pharmacological properties and potential therapeutic applications.
The journal has demonstrated a dynamic evolution in its focus, reflecting contemporary challenges and interests in the pharmaceutical sciences. Recent publications indicate several emerging themes that are gaining traction among researchers.
  1. Digital Health and Technology in Pharmacy:
    An increasing number of studies explore the integration of digital tools and technologies in pharmacy practice, including telepharmacy and data analytics for improving patient outcomes.
  2. Patient-Centric Research:
    Research emphasizing patient engagement, adherence to therapy, and the role of pharmacists in community settings is on the rise, highlighting the importance of patient perspectives in pharmaceutical care.
  3. Pharmacogenomics and Personalized Medicine:
    Emerging research on the genetic basis of drug response is gaining attention, with implications for tailoring therapies to individual patients based on their genetic profiles.
  4. Impact of Pandemics on Drug Use and Patient Care:
    The COVID-19 pandemic has spurred a significant increase in studies evaluating drug use patterns, vaccine safety, and the role of pharmacists in managing public health crises.
  5. Sustainable Pharmaceutical Practices:
    There is a growing trend towards research focusing on sustainability in pharmaceutical manufacturing and drug delivery systems, reflecting global concerns about environmental impact.

Declining or Waning

While Ars Pharmaceutica continues to expand its research horizons, certain themes have shown a decline in frequency or interest. This shift may reflect evolving priorities within the field or changing research landscapes.
  1. Traditional Medicinal Practices:
    Research focusing on traditional herbal medicines and their applications has seen a reduction, possibly due to an increasing emphasis on evidence-based and clinical research.
  2. Pharmaceutical Marketing and Regulations:
    Themes related to the marketing authorization of drugs and regulatory affairs have become less prominent, suggesting a shift towards more practical clinical applications and patient-centered research.
  3. Single Disease Focus Studies:
    Studies addressing specific diseases without broader implications or interdisciplinary approaches have decreased, indicating a trend towards more integrated and holistic health research.
  4. Historical Perspectives in Pharmacy:
    Papers exploring historical aspects of pharmaceutical practices and education have waned, as current research trends lean towards contemporary issues and advancements.

Similar Journals

Journal of Young Pharmacists

Innovating the Future of Pharmaceutical Sciences
Publisher: INPHARM ASSOC, PHCOG NETISSN: 0975-1483Frequency: 4 issues/year

Journal of Young Pharmacists is a distinguished peer-reviewed journal published by INPHARM ASSOCIATION in collaboration with PHCOG NET. With an ISSN of 0975-1483 and an E-ISSN of 0975-1505, this journal serves as a vital platform for disseminating pioneering research in the field of pharmacology and toxicology. Although coverage in Scopus was discontinued in 2018, the journal continues to be important in educating future pharmacists and advancing the discipline, evident from its ranking in the 29th percentile among general pharmacology journals. The Journal of Young Pharmacists seeks to bridge the gap between theoretical knowledge and practical application, encouraging young researchers, professionals, and students to contribute their insights and findings. The journal emphasizes innovative approaches and contemporary issues relevant to the pharmaceutical sciences, making it an invaluable resource for anyone involved in this dynamic field.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Exploring new frontiers in tropical pharmaceutical research.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.

Journal of Pharmaceutical Health Care and Sciences

Empowering healthcare through cutting-edge pharmaceutical research.
Publisher: BMCISSN: 2055-0294Frequency: 1 issue/year

The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.

Acta Pharmaceutica Sinica B

Championing Excellence in Pharmaceutical Research
Publisher: INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCESISSN: 2211-3835Frequency: 6 issues/year

Acta Pharmaceutica Sinica B is a prestigious open access journal that has been setting the standard in the field of pharmacology, toxicology, and pharmaceutics since its establishment in 2011. Published by the Institute of Materia Medica, Chinese Academy of Medical Sciences, the journal serves as a vital platform for researchers, professionals, and students seeking to disseminate innovative findings in drug development, pharmaceutical sciences, and therapeutic applications. With an impressive impact factor reflecting its high academic quality, Acta Pharmaceutica Sinica B has achieved Q1 status in the category of Pharmacology, Toxicology and Pharmaceutics as of 2023, ranking #1 out of 80 journals in General Pharmacology. This journal not only focuses on the latest advancements in drug research and formulation but also emphasizes interdisciplinary approaches, fostering collaborations that span various scientific domains. The accessible nature of the journal, combined with its rigorous peer-review process, ensures that crucial insights and breakthroughs reach a global audience swiftly and effectively. For those looking to stay at the forefront of pharmaceutical research, Acta Pharmaceutica Sinica B is an indispensable resource.

DARU-Journal of Pharmaceutical Sciences

Connecting groundbreaking studies with clinical applications.
Publisher: SPRINGER INT PUBL AGISSN: Frequency: 2 issues/year

DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.

Iranian Journal of Pharmaceutical Research

Connecting scholars to elevate the standards of drug research.
Publisher: BRIEFLANDISSN: 1735-0328Frequency: 4 issues/year

Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Transforming Ideas into Effective Therapies
Publisher: TAYLOR & FRANCIS LTDISSN: 0363-9045Frequency: 12 issues/year

Drug Development and Industrial Pharmacy is a prestigious journal published by Taylor & Francis Ltd, focusing on the critical field of pharmaceutical sciences. With an ISSN of 0363-9045 and an E-ISSN of 1520-5762, the journal has been an essential resource for researchers and professionals since its inception in 1974. It occupies a crucial niche within Drug Discovery, Organic Chemistry, and Pharmaceutical Science, currently ranked in the second and third quartiles, reflecting its solid contribution to the field. The journal encompasses a wide array of topics, including drug development processes, formulation, and industrial manufacturing alongside cutting-edge research in pharmacology and toxicology. With a commendable Scopus ranking demonstrating high relevance—ranked #44 in Pharmaceutical Science—it serves as a vital forum for academia and industry to share innovative findings and methodologies. While it does not offer open access, the journal remains an invaluable resource for those seeking to advance their knowledge and enhance their research in pharmaceutical development.

Advances in Pharmacology and Pharmacy

Pioneering Discoveries in Drug Development
Publisher: HORIZON RESEARCH PUBLISHINGISSN: 2332-0036Frequency: 3 issues/year

Advances in Pharmacology and Pharmacy is a pioneering journal devoted to the dissemination of cutting-edge research in the fields of pharmacology and pharmaceutical sciences. Published by Horizon Research Publishing, this peer-reviewed journal boasts a commitment to advancing knowledge and innovation, making it an essential resource for researchers, industry professionals, and students alike. With an ISSN of 2332-0036 and an E-ISSN of 2332-0044, it provides a platform for high-quality research articles that explore new therapeutic approaches, drug development strategies, and the regulatory aspects of pharmaceutical science. Although currently lacking a formal impact factor, the journal's emphasis on open access ensures that articles are widely available, promoting the sharing of valuable insights and collaborative efforts in the scientific community. Located at 506 N Garfield Ave, Ste 210, Alhambra, CA 91801, the journal welcomes contributions from diverse areas within pharmacology and pharmacy, reinforcing its significance as a vital resource in the ever-evolving landscape of pharmaceutical research.

JOURNAL OF PHARMACEUTICAL SCIENCES

Unveiling the science behind effective therapies and innovations.
Publisher: ELSEVIER SCIENCE INCISSN: 0022-3549Frequency: 12 issues/year

The JOURNAL OF PHARMACEUTICAL SCIENCES, published by ELSEVIER SCIENCE INC, stands as a cornerstone in the field of pharmaceutical sciences, offering a platform for innovative research and advancements since its inception in 1961. With an impressive Scopus Rank of #36 out of 183 in the Pharmaceutical Science category, this journal is recognized for its commitment to disseminating high-quality, peer-reviewed studies that significantly contribute to the realms of pharmacology, toxicology, and pharmaceutics. Holding a 2023 Q2 category quartile, it attracts a diverse readership encompassing researchers, industry professionals, and students eager to advance their understanding and expertise. While the journal is not open access, it ensures valuable insights in every issue, making it an essential resource for those dedicated to the evolving landscape of pharmaceutical research. With an impact factor that reflects its relevance and influence, the JOURNAL OF PHARMACEUTICAL SCIENCES continues to shape the discourse in its domain, fostering innovation and collaboration among scholars worldwide.

ACTA PHARMACEUTICA

Advancing pharmaceutical innovation for a healthier tomorrow.
Publisher: SCIENDOISSN: 1330-0075Frequency: 4 issues/year

ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.